Promising heterocycle-based scaffolds in recent (2019–2021) anti-Alzheimer's drug design and discovery

Alzheimer's disease (AD) is one of the neurodegenerative diseases that led to morbidity and mortality world-wide. It is a complex disease whose etiology is not completely known that leads to difficulty in prevention or cure of the AD. Also, there are only few approved drugs for AD treatment. Ap...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	European journal of pharmacology 2022-04, Vol.920, p.174847-174847, Article 174847
1. Verfasser:	Dorababu, Atukuri
Format:	Artikel
Sprache:	eng
Schlagworte:	Alzheimer Disease - drug therapy Alzheimer's disease Amyloid beta-Peptides Aβ-aggregation inhibitory activity Cholinesterase inhibitors Cholinesterase Inhibitors - pharmacology Cytotoxicity Drug Design Drug Discovery Humans Monoaminase inhibitors Structure-Activity Relationship
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!